首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1439302

呼吸器-全球市場回顧、競爭格局、市場預測（2030）

Ventilators - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2024年至2030年的預測期內，全球呼吸器市場規模預計將以11.65%的複合年增長率成長。呼吸器市場的需求主要是由哮喘、慢性阻塞性肺病（COPD）、支氣管炎和肺癌等呼吸系統疾病的高發病率、先進設備的推出以及COVID-19等流行病的影響推動的這是由於疫情、加護病房（ICU）和ICU 床位的增加所致。

呼吸器市場動態

由於全球呼吸系統疾病負擔日益加重，呼吸器市場正在顯著成長。呼吸系統疾病是全世界死亡的主要原因之一。根據世界衛生組織(WHO)統計，2019年慢性阻塞性肺病(COPD)在全球造成323萬人死亡，成為第三大死因。根據相同統計數據，環境暴露於菸草煙霧、室內空氣污染、職業粉塵、煙霧和化學物質是慢性阻塞性肺病的重要危險因子。

根據世界衛生組織的數據，2018 年，低收入和中等收入國家成年人中四分之一（即 25%）的慢性阻塞性肺病死亡可歸因於家庭空氣污染。家庭空氣污染會導致慢性阻塞性肺病和肺癌等非傳染性疾病。例如，美國癌症協會估計，2022年美國將有235,760例肺癌病例。因此，氣喘和慢性阻塞性肺病的激增將有助於全球呼吸器市場的成長。

全球呼吸器市場的成長預計也將受到重症監護病房（ICU）和 ICU 床位增加的影響。這是因為重症監護病房 (ICU) 和 ICU 床位的增加可能會增加住院率和再入院率，並且需要更頻繁的呼吸支持。

此外，患者通氣和供氧的自動控制、即時同步以及從固定設備到便攜式設備的過渡等技術進步正在推動全球呼吸機市場的發展。

COVID-19 大流行導致呼吸道疾病的發生率普遍增加。 COVID-19 大流行對全球呼吸器市場產生了重大影響。在大流行期間，對呼吸器的需求增加，因為它們是拯救受影響人群生命的唯一選擇。此外，許多公司正在擴大生產能力以滿足不斷增長的需求。例如，2020年3月，佐爾醫療公司實施了一項計劃，將其呼吸機製造能力提高到每月10,000台。產量的增加將有助於治療患有 COVID-19 的患者，最終導致市場擴張。預計未來需要機械通氣的患者數量將迅速增加，增加對呼吸器的需求，並可能加快呼吸器市場的成長速度。

某些因素對呼吸器市場的成長構成了小障礙，例如某些設備對新生兒的負面影響、零件供應鏈管理以及與使用有創呼吸器相關的問題。

呼吸器市場區隔分析

在呼吸器市場的行動領域，便攜式呼吸器領域是 2024-2030 年預測期內全球呼吸器市場成長最快的領域。該產品領域的快速成長可歸因於其在醫院的廣泛使用，因為它甚至在患者到達醫院之前就可以為患者提供方便、快速和持續的護理。自 COVID-19 大流行開始以來，對便攜式呼吸器的需求一直在增加。因此，即使治療被延遲，疾病治療需求的上升也將有利於便攜式呼吸器市場。

此外，新產品的核准也可能推動呼吸器市場在預測期內快速成長。例如，2022年8月，Max Ventilator宣布推出高流量氧氣治療（HFOT）設備，並在其新的呼吸器產品類別中推出WeanX。

本報告提供了全球呼吸器市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

呼吸器市場促進因素
- 呼吸道疾病高發生率
- 新冠肺炎 (COVID-19) 大流行的爆發
- 增加加護病房 (ICU) 和 ICU 床位
- 技術進步
呼吸器市場的限制與挑戰
- 某些設備對新生兒的不良影響
- 與使用侵入性機械通氣相關的問題
呼吸器市場的機遇
- 通風技術的進步
- 新興國家的成長機會

第 5 章呼吸器的波特五力分析

第 6 章COVID-19對呼吸器市場的影響分析

第 7 章呼吸器市場佈局

依流動性
- 重症監護呼吸器
- 便攜式/行動呼吸機
依類型
- 成人/兒童呼吸器
- 新生兒/嬰兒呼吸器
按介面
- 侵入性通氣
- 無創通氣
按最終用戶
- 醫院
- 居家護理
- 門診手術中心
- 其他
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章呼吸器：全球公司份額分析 - 3 至 5 家主要公司

第 9 章呼吸器公司及產品簡介

Hamilton Medical
Medtronic PLC
Vyaire Medical, Inc.
Getinge AB
ResMed
Air Liquide
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Fisher & Paykel Healthcare Limited
Smiths Group PLC
ACUTRONIC Medical Systems AG
Dragerwerk AG & Co. KGaA
SCHILLER AG
Bunnell Incorporated
Leistung Equipamentos LTDA
ZOLL Medical Corporation
Koninklijke Philips N.V.
Nihon Kohden Corporation
General Electric Company
Allied Healthcare Products, Inc.
aXcent Medical GmbH

第 10 章專案方法

輔助材料
主要來源
數據三角測量
主要專家意見

第 11 章KOL瀏覽量

第 12 章DelveInsight服務內容

第 13 章免責聲明

第 14 章關於 DelveInsight

簡介目錄圖表

Product Code: DIMDCL0093

Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to lauch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Global Ventilators Market is expected to grow at a CAGR of 11.65% during the forecast period from 2024 to 2030. The demand for Ventilators Market is primarily attributed to the high prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, lung cancer, launch of advanced devices, rise in outbreak pandemics such as COVID-19, growing numbers of intensive care units (ICU), and ICU beds.

Ventilators Market Dynamics:

Ventilators Market has significantly risen owing to the growing burden of respiratory diseases across the globe. Respiratory diseases are among the leading causes of death in the world. Chronic obstructive pulmonary disease (COPD) is the third-most-leading cause of death, causing 3.23 million deaths worldwide in 2019, as per World Health Organization (WHO). As per the same statistics, environmental exposure to tobacco smoke, indoor air pollution, and occupational dust, fumes, and chemicals are important risk factors for COPD.

According to WHO, 2018, one in four or 25% of deaths from COPD in adults in low- and middle-income countries are owing to the exposure to household air pollution. Household air pollution causes noncommunicable diseases including COPD and lung cancer. For instance, As per, American Cancer Society's estimates in the United States there wil be around 235,760 cases in 2022 for lung cancer, Thus, the burgeoning cases of asthma and COPD will contribute to the Global Ventilators Market growth.

The growth of the global ventilator market is also projected to be influenced by growing numbers of intensive care units (ICU) and ICU beds. The rising prevalence of these increases hospital admission rates and readmission of the affected patients as they may require frequent ventilation support.

Moreover, advancements in technologies like automated control of the patient's ventilation and oxygenation, real-time synchronization, and the shift in trend from fixed to portable equipment are fuelling the Global Ventilators Market.

COVID-19 outbreak has extensively caused an increased incidence of respiratory diseases. The COVID-19 pandemic had a profound impact on Ventilators Market across the globe. The demand for ventialtors is increased during the pandemic as it is the only option for the life saving for the affected individuals. Further, many companies have scaled up ther manufacturing capacity to meet the rising demand. For instance, in March 2020, Zoll Medical Corporation executed a plan to increase manufacturing capacity to 10,000 ventilators per month. This production volume expansion helped in the treatment of patients suffering from COVID-19 and ultimately led to market expansion. It is further expected that there will be a surge in the number of patients requiring ventilation support, and there may be an increase in the demand for ventilators, which might fasten the pace of the Ventilators market growth.

Certain factors such as the adverse impact of certain devices on neonates, the management of supply chains of parts, and problems associated with the use of invasive ventilators pose a minor hurdle for the growth of the Ventilators market.

Ventilators Market Segment Analysis:

Ventilators Market by Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), Ventilators Market by Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), Ventilators Market by Interface (Invasive Ventilation, Non-Invasive Ventilation), Ventilators Market by End User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), and Ventilators Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In Ventilators Market mobility segment, the Portable Ventilators segment is the fastest growing segment in the Global Ventilators market during the forecast period from 2024-2030. The rapid growth of this product segment can be attributed to their widespread use in hospitals owing to their convenience, faster, and continuous care to patients even before their arrival in the hospital premises. Since the beginning of the COVID-19 pandemic, the demand for Portable Ventilators has been on the rise. Therefore, the growing demand for disease treatment benefits the portable ventilator market, even if the procedure is delayed.

In addition, new product approvals are also likely to upsurge the Ventilators market during the forecasted period. For instance, in August 2022, the Max Ventilator announced the launch of the High Flow oxygen Therapy (HFOT) device and WeanX in its new ventilator range category.

Additionally, innovators are coming up with lightweight, cost-effective ventilators to tackle COVID-19. For instance, in 2020, Marico Innovation Foundation has offered Rs 85 lakhs to winners of an innovation challenge for developing unique, disruptive, accessible, and affordable ventilators.

Moreover, new/existing hospitals and healthcare centers in rural regions of developing countries such as India, China, Brazil, are equipping with advanced facilities for patient comfort, which is expected to enhance the market potential. Hence, all the above-mentioned factors are expected to drive the segment growth of the Ventilators market as the demand is rising owing to the rising diseases requiring ventilation support.

North America is expected to dominate the overall Ventilators Market:

North America is expected to dominate the overall Ventilators market during the forecast period. This domination is owing to the increasing respiratory diseases, technological advancements in the products, new product launches, and outbreak of the epidemics and pandemics such as COVID-19. As per World Health Organization, as of September 29, 2022, 232,636,622 confirmed COVID-19 cases and 4,762,089 deaths were reported across the globe. The United States accounted for 18.42% of global COVID-19 confirmed cases. Such type of disease is expected to increase the demand of Ventilators in the region.

Further, the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong adoption of advanced technologies. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the market. For instance, in May 2022, California-based CorVent Medical announced that it received CE mark approval for its Respond-19 ventilator and is preparing to launch it in Europe. The system received FDA emergency use authorization (EUA) for primary critical care use in December 2020 and is expected to propel the market growth of Ventilators.

Europe and Asia-Pacific region have the future potential growth for the Global Ventilators market. This is owing to the increase in the number of Hospitals and ICU beds in the European region countries and Asian countries also. According to Eurostat, 2018, an analysis of the number of hospital beds in relation to population revealed that there were, on average, 538 per 100 000 inhabitants across the whole of the EU-27. Among the EU Member States, Germany recorded not only the highest number of hospital beds (661,000; 2017 data), but also the highest number relative to population size, with 800 hospital beds per 100,000 population; Bulgaria, Austria, and Hungary also recorded more than 700 hospital beds per 100,000 inhabitants, which indicates that there is a constant rise on the no. of beds in the region. Thus the above-mentioned factors is expected to drvie the growth of Ventilators Market.

Moreover, the high adoption rate of technological advancements owing to the rise in healthcare expenditure by the European government. Also, rising respiratory diseases is one of the leading chronic diseases in the European region leads to an increase in demand for Ventilators. For instance, the mortality rate from respiratory disease in England in 2018 was 161 deaths per 100,000 population for men and 117 per 100,000 for women according to the World Health Statistics, 2018. Thus, prevention of these diseases

Ventilators Market Key Players:

Some of the key market players operating in the Ventilators market include Hamilton Medical, Medtronic PLC, Vyaire Medical, Inc., Getinge AB, ResMed, Air Liquide, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Fisher & Paykel Healthcare Limited, Smiths Group PLC, ACUTRONIC Medical Systems AG, Dragerwerk AG & Co. KGaA, SCHILLER AG, Bunnell Incorporated, Leistung Equipamentos LTDA, ZOLL Medical Corporation, Koninklijke Philips N.V., Nihon Kohden Corporation, General Electric Company, Allied Healthcare Products, Inc., aXcent Medical GmbH and others.

Recent Developmental Activities in the Ventilators Market:

On September 25, 2022, Emerson announced a partnership with BioBusiness, an Egyptian medical equipment manufacturer, to design and produce a variety of ventilators that will use Emerson's ASCO(TM) valves and AVENTICS(TM) regulators to offer accurate pressure and gas flow control.

In August 28, 2022, Ventilator maker Max Ventilator entered into a technology collaboration agreement with US-based respiratory technology player Amptron Medical to match global standards.

On May 18, 2022, CorVent Medical announced that their RESPOND-19(TM) Ventilator has gained CE Mark certification and is ready for commercial launch in Europe.

Key Takeaways from the Ventilators Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Ventilators market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Ventilators Market.

Various opportunities are available for the other competitor in the Ventilators Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Ventilators market growth in the coming future?

Target Audience who can be benefited from this Ventilators Market Report Study

Ventilators providers

Research organizations and consulting companies

Ventilators related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Ventilators

Various End-users want to know more about the Ventilators Market and the latest technological developments in the Ventilators market.

Frequently Asked Questions for Ventilators Market:

1. What are Ventilators?

Ventilators are devices used for critically ill patients who cannot breathe or pump oxygen into their lungs.

2. What is the market for Global Ventilators?

Global Ventilators Market is expected to grow at a CAGR of 11.65% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Ventilators?

The major drivers driving the demand for Ventilators are the high prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, lung cancer, the outbreak of the COVID-19 pandemic, growing numbers of intensive care units (ICU), and ICU beds and rising technological advancements.

4. What are the key players operating in Global Ventilators?

5. Which regions has the highest share in the Ventilators market?

North America is expected to dominate the overall Ventilators market during the forecast period, 2024 to 2030. This domination is due to the outbreak of the COVID-19 pandemic, and the high adoption of technological advancements owing to the rise in healthcare expenditure by the US government.

1.Ventilators Market Report Introduction

2. Ventilators Market Executive summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

3.1. The United States
3.2. Europe
- 3.2.1. Germany
- 3.2.2. France
- 3.2.3. Italy
- 3.2.4. Spain
- 3.2.5. The U.K.
3.3. Japan

4. Ventilators Market Key factors analysis

4.1. Ventilators Market Drivers
- 4.1.1. High prevalence of respiratory diseases
- 4.1.2. The outbreak of the COVID-19 pandemic
- 4.1.3. The growing numbers of intensive care units (ICU), and ICU beds
- 4.1.4. The rising technological advancements
4.2. Ventilators Market Restraints and Challenges
- 4.2.1. The adverse impact of certain devices on neonates
- 4.2.2. Problems associated with the use of invasive ventilators
4.3. Ventilators Market Opportunities
- 4.3.1. Technological advances in ventilation
- 4.3.2. Growth opportunities in emerging countries

5. Ventilators Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Ventilators Market

7. Ventilators Market layout

7.1. By Mobility
- 7.1.1. Intensive Care Ventilators
- 7.1.2. Portable/Transportable Ventilators
7.2. By Type
- 7.2.1. Adult/Pediatric Ventilators
- 7.2.2. Neonatal/Infant Ventilators
7.3. By Interface
- 7.3.1. Invasive Ventilation
- 7.3.2. Non-Invasive Ventilation
7.4. By End User
- 7.4.1. Hospitals
- 7.4.2. Home Care
- 7.4.3. Ambulatory Surgical Centers
- 7.4.4. Others
7.5. By Geography
- 7.5.1. North America
  - 7.5.1.1. North America Ventilators Market, by Mobility
  - 7.5.1.2. North America Ventilators Market, by Type
  - 7.5.1.3. North America Ventilators Market, by Interface
  - 7.5.1.4. North America Ventilators Market, by End User
  - 7.5.1.5. North America Ventilators Market, by Country
  - 7.5.1.5.1. United States
  - 7.5.1.5.2. Canada
  - 7.5.1.5.3. Mexico
- 7.5.2. Europe
  - 7.5.2.1. Europe Ventilators Market, by Mobility
  - 7.5.2.2. Europe Ventilators Market, by Type
  - 7.5.2.3. Europe Ventilators Market, by Interface
  - 7.5.2.4. Europe Ventilators Market, by End User
  - 7.5.2.5. Europe Ventilators Market, by Country
  - 7.5.2.5.1. France
  - 7.5.2.5.2. Germany
  - 7.5.2.5.3. United Kingdom
  - 7.5.2.5.4. Italy
  - 7.5.2.5.5. Spain
  - 7.5.2.5.6. Russia
  - 7.5.2.5.7. Rest of Europe
- 7.5.3. Asia-Pacific
  - 7.5.3.1. Asia-Pacific Ventilators Market, by Mobility
  - 7.5.3.2. Asia-Pacific Ventilators Market, by Type
  - 7.5.3.3. Asia-Pacific Ventilators Market, by Interface
  - 7.5.3.4. Asia-Pacific Ventilators Market, by End User
  - 7.5.3.5. Asia-Pacific Ventilators Market, by Country
  - 7.5.3.5.1. China
  - 7.5.3.5.2. Japan
  - 7.5.3.5.3. India
  - 7.5.3.5.4. Australia
  - 7.5.3.5.5. South Korea
  - 7.5.3.5.6. Rest of Asia Pacific
- 7.5.4. Rest of the World (RoW)
  - 7.5.4.1. RoW Ventilators Market, by Mobility
  - 7.5.4.2. RoW Ventilators Market, by Type
  - 7.5.4.3. RoW Ventilators Market, by Interface
  - 7.5.4.4. RoW Ventilators Market, by End User
  - 7.5.4.5. RoW Ventilators Market, by Region
  - 7.5.4.5.1. Middle East
  - 7.5.4.5.2. Africa
  - 7.5.4.5.3. South America

8. Ventilators Global Company Share Analysis - Key 3-5 Companies

9. Ventilators Company and Product Profiles

9.1. Hamilton Medical
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. Medtronic PLC
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. Vyaire Medical, Inc.
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. Getinge AB
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. ResMed
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. Air Liquide
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. Fisher & Paykel Healthcare Limited
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Smiths Group PLC
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. ACUTRONIC Medical Systems AG
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. Dragerwerk AG & Co. KGaA
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. SCHILLER AG
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. Bunnell Incorporated
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Leistung Equipamentos LTDA
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. ZOLL Medical Corporation
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Koninklijke Philips N.V.
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. Nihon Kohden Corporation
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. General Electric Company
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Allied Healthcare Products, Inc.
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. aXcent Medical GmbH
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy